Professional Documents
Culture Documents
COROMANDEL REPORT
COROMANDEL REPORT
Valuation view
• The company achieved a year-on-year growth of 30% in Q4FY23 (IN INR b) FY23 FY24E FY25E
compared to Q4FY22.
• The gross margin of the company stood at 20.8% in FY23, down Net Revenue 296.30 257.10 270.70
from 25.6% in FY22. EBITDA 29.3 28.7 30.9
• The decline in segment revenue during this quarter was attributed EBITDA
to lower primary sales by 7% and a decrease in subsidy rates. Margin(%) 9.90 11.20 11.4
• However, the bio product business of the company showed ROE(%) 28.2 23 20.9
improvement in procurement during the year. ROCE(%) 30.5 24.1 21.7
• Additionally, the business successfully commissioned a state-of- EPS(inr) 68.5 68 73.6
the-art sulfuric acid plant at Vishakhapatnam, with a capacity of
EV/EBITDA(x) 9.2 8.9 8
1650 tons per day, involving an investment of 400 crores.
Academic Research Project –Not a Recommendation
Global Economy
The global economy experienced a significant shock due to the Global GDP Projections
COVID-19 pandemic. While many countries witnessed a sharp
recovery post-COVID, CY22 proved to be a challenging period 0.50% 5.50%
characterized by high inflation, increased cost of living, and a
World
surge in energy prices. Additionally, geopolitical tensions
between Russia and Ukraine disrupted trade and supply chains, Advanced
affecting Western countries. Central banks worldwide are Economics
combating inflation through rate hikes. The recent conflict Emerging
between Israel and Gaza presents further challenges, particularly Economics
in energy costs and supply chain stability. Consequently, Euro area
developed economies grew at a slower pace of 2.7% compared
to 5.0% in CY 2021, while emerging and developing economies US
posted growth of 4.5% versus 6.5% in CY 2022. Within the Euro
region, companies with a dominant international presence grew Japan
at 3.5% compared to 5.2% in CY 2022. Overall, the global
economy witnessed a growth rate of 3.4% in CY 2022, down UK
from 5.0% previously. Global growth is projected to decrease
from an estimated 3.5% in CY22 to 3.0% in both CY 23 and CY 24. China
While the CY23 forecast is slightly higher than previously
anticipated, it remains weak compared to historical standards. India
The continued rise in central bank policy rates aimed at
combating inflation continues to weigh on economic activity. 2022A 2023P 2024P
Global headline inflation is expected to decline from 8.7% in
CY22 to 6.8% in CY23 and further to 5.2% in CY24.
Source IMF WEO,RBI,SBI Research company analysis
Indian economy India GDP growth
FY23 marked a year of significant achievement for India as it
surpassed the UK to become the 5th largest economy globally. 10.00% 8.00%
India recorded a growth rate of 7.2% in FY23, surpassing the 5.00% 6.00%
global average of 3.5%. Despite facing various global economic 4.00%
challenges such as the post-COVID impact, supply chain 0.00% 2.00%
disruptions, increased inflation, and interest rate hikes, the 2018 2019 2020 2021 2022 2023 2024 0.00%
Indian economy exhibited resilience and sustained growth. This -5.00% -2.00%
growth was fueled by government initiatives across multiple
-10.00% -4.00%
fronts, including the PLI scheme, National logistic reforms,
increased infrastructure spending, robust local demand, and India Global
fast-paced digitalization. According to a note from SBI Research
Economist, India is expected to become the third-largest
economy by FY28, two years earlier than projected. The SBI
economist further forecasted a growth rate of 8.1% in the first India GDP Quarterly growth Actual vs
Projected
quarter of FY24, pushing the overall growth rate to 6.5%. India
recorded a growth rate of 13.5% in the first quarter of FY23. This 16.00%
forecast aligns with RBI projections of 6.5% growth in FY24 but is 14.00%
more optimistic than the International Monetary Fund’s revised 12.00%
forecast of 6.1%. Earlier this week, the IMF revised its growth 10.00%
forecast upwards by 0.2 percentage points on the back of strong 8.00%
domestic investment. On the demand front, urban consumption 6.00%
remains flat while rural demand shows signs of revival. 4.00%
Investment activity is benefiting from public sector capex, and 2.00%
strong growth is observed in imports and the production of
capital goods. Additionally, inflation is expected to soften and
fall within the targeted range soon. The Indian economy is Actual Projected
robustly progressing towards becoming the 3rd largest economy
with a $5 trillion GDP. Source IMF WEO,RBI,SBI Research company analysis
Academic Research Project –Not a Recommendation
Source:stastica,company analysis
Academic Research Project –Not a Recommendation
Economic Outlook:
• The global economy is experiencing a muted recovery, with inflationary pressure and geopolitical issues
persisting.
• The Indian economy is the fastest-growing large economy, with a revised GDP growth of 6.1% in Q1FY23,
while global growth is approximately 3% in Q2FY23.
Financial Performance:
• Coromandel International demonstrated steady performance in Q1, marked by volume growth in fertilizer
and sustained profitability.
• The company recorded a consolidated total income of INR 5,738 crores in Q1, accompanied by an EBITDA
of INR 709 crores.
• In Q2FY23, the consolidated total income amounted to Rs 7,033 Crores, with a net profit after tax of Rs
755 Crores
• The subsidy outstanding as of September 30, 2023, stood at Rs 1,497 Crores.
• Coromandel International maintains a long-term credit rating of CRISIL AAA stable and a short-term rating
of CRISIL A1+.
• The rupee traded in a range of 81.81 to 83.30 during the quarter.
Export Market:
• The Crop Protection business has grown by 17% in the export market, with plans to launch novel
combination and technical products in Q1FY23
Commentary
Capex
According to a report by Crisil, the Indian agrochemicals sector is poised to experience a 3 percent revenue
decline in the current fiscal year, attributed to diminishing prices, sluggish demand, and reduced reservoir levels.
This downturn is primarily driven by an influx of supply from China, dwindling export demand, and the adverse
effects of lower reservoir levels on winter crop planting. Operating margins are expected to decline by 400-450
basis points this financial year due to decreased sales volumes and realizations, impacting cash flows for
agrochemical companies. The prevailing subdued demand is prompting manufacturers in the agrochemical sector
to scale back their capital expenditure plans. Despite the anticipated revenue decline of 3% in FY24, robust
balance sheets should provide adequate resilience to weather business challenges. In the Specialty Chemicals
category, substantial growth is anticipated, with forecasts suggesting a value of approximately $50 billion by
2025.
Import
Relying heavily on rock phosphate imports underscores India's need to enhance its long-term sustainability and
supply security objectives, a goal that investments in BMCC aim to achieve for meeting the nation's fertilizer
demands. As a net importer of sulphuric acid, India stands as the third-largest importer globally, with imports
totaling close to 20 lakh metric tonnes. Despite being the second most utilized fertilizer in India, Di-Ammonium
Phosphate (DAP) sees over 50% of its requirement met through imports, highlighting the country's dependency
on external sources.
Export
In FY23, although the budgetary allocation for Urea and NPK fertilizers stood at INR 1.05 lakh crore, a
substantial amount of INR 2.5 lakh crore was disbursed towards fertilizer subsidies. Looking forward, the
affordability of fertilizers has been steadily improving, buoyed by decreasing fertilizer prices and a more
favorable energy situation in Europe, thanks to robust stocking and a mild winter. Anticipated enhancements in
fertilizer demand for FY2024 are expected to compensate for the previous year's application shortfall.
Moreover, supply prospects are set to ameliorate with enhanced manufacturing capacities in key production
centers and the potential relaxation of export restrictions by global suppliers. On the front of crop protection,
there is a discernible trend of global agrochemical firms seeking diversified sourcing options, with India poised
as a robust manufacturing base. Notably, the country's total foodgrain production is estimated to reach a record
323 million MT, further underlining the sector's growth trajectory. Forecasts indicate a potential surge, with
approximately USD 50 billion worth of agricultural and livestock produce slated for export this year. However,
recent export sanctions on Russia and Belarus, major players in global potash and nitrogenous fertilizers trade,
have introduced significant volatility into the global markets. Added strain from export restrictions imposed by
China has exacerbated supply pressures amidst an already constrained global availability. Additionally, soaring
costs of raw materials such as natural gas and ammonia have contributed to record-high production expenses
for fertilizer manufacturers. The looming threat of diminished global supply has triggered a swift escalation in
fertilizer prices and intensified demand dynamics..
Academic Research Project –Not a Recommendation
Commentary
The company benefits from strong management with extensive experience and technical expertise. Its board of
independent directors' hails from diverse industries and includes respected professionals such as a former Union
Finance Secretary, ex-CFO, research faculty, and development economists. Upon scrutinizing available data, no
prominent political affiliations have been found between the leadership and independent directors with national or
regional political parties. Additionally, there are no reported conflicts of interest between the independent directors
and the company. Mr. A. Vellayan, the company's chairman, brings significant experience in the fertilizers business,
general management, and financial planning, having previously served as the vice chairman of the Murugappa Group
Shareholding Pattern
Particular Sep-21 Dec-21 Mar-22 Jun-22 Sep-22 Dec-22 Mar-23 Jun-23 Sep-23
Promoters 57.54% 57.53% 57.53% 57.48% 57.45% 57.41% 57.41% 57.41% 57.34%
FIIs 7.63% 7.21% 7.08% 8.04% 9.93% 10.26% 9.40% 7.56% 7.18%
DIIs 21.12% 21.74% 21.23% 20.06% 18.65% 18.00% 18.86% 20.59% 21.11%
Public 13.71% 13.52% 14.17% 14.43% 13.97% 14.34% 14.33% 14.46% 14.37%
Management analysis
Independent director
S.N
O Name Designation Qualification
He holds a Master’s Degree in Social Policy and Planning from the
London School of Economics and a Master of Arts from St.
Stephen’s College, Delhi. Having joined the Indian Administrative
Service in 1976, Mr. Bose served in various positions in the
Government of Madhya Pradesh and the Government of India
before retiring as the Union Finance Secretary, Government of
India. In the Finance Ministry he served as Secretary , Secretary and
Independent
Mr.Sumit Bose Secretary as well as Secretary in the Thirteenth Finance
1 director
Commission. Mr. Bose is currently on the boards of HDFC Pension
Management Company Limited, HDFC Life Insurance Company
Limited, TATA AIG General Insurance Company Limited, JM
Financial Limited, J B Chemicals and Pharmaceuticals Limited and
other companies. He also serves on the Boards of non-profit
organisations such as Nidhi Centre for Legal Policy, Water Aid India,
Parivaar and Foundation to Educate Girls Globally.
She has extensive background in General Management and
Strategic Financial Planning. She is a Science Graduate (Hons) from
the University of Sussex and pursued Owners Management
Programme from Harvard Business School and Strategic Financial
Ms.Aruna Independent Planning from IIM Ahmedabad. Having been associated with Ador
2
B.Advani Director Welding Limited for over four decades, during which she served as
Executive Chairman, she continued to be part of the Boards of
various associated companies. Ms. Advani is presently on the Board
of Metro Brands Limited, leveraging her valuable experience and
insights to assist the company in its endeavours.
He is a Chartered Accountant and holds a Post Graduate Diploma in
Management from IIM Ahmedabad. He started his career in Asian
Paints Limited and, thereafter, worked with Citigroup for twenty
years in multiple roles in India, Australia, South Korea, UAE and the
UK. His last role in Citigroup was as the Regional Chief Financial
Officer for the Europe and Middle East divisions for the Consumer
Mr.K V Independent Bank. He then worked as the Chief Financial Officer of a start-up
3
Parameshwar Director financial services entity- Dunia Group – in the UAE from 2010 till
early 2018. He is currently the head of Administration and Finance
at the Wildlife Conservation Society – India and holds Directorship
in 360 One Asset Trustee Limited. Mr. Parameshwar has more than
30 years of experience and expertise in Business and Financial
Management including Control, Reporting, Taxation, Treasury and
Legal.
Academic Research Project –Not a Recommendation
Mr. Venu holds a Graduate Degree with Honors in the Jerome Fisher
Program in Management and Technology . He holds B.S. in Mechanical
Engineering from the School of Engineering and Applied Sciences and B.S. in
Mr.Sudarsha Independen
5 n Venu t director
Economics . He has also completed M.Sc. in International Technology
Management . He is the Managing Director of TVS Motor Company Limited ,
Non-Executive Director in Sundaram-Clayton Ltd and Chairman of TVS Credit
Services Ltd
she is a former executive director of the Reserve Bank of India (RBI). She is a
a public policy professional, a development economist, policy analyst and a
writer on economic subjects. At RBI, her responsibilities included heading
the Department of Currency Management, Legal Department, Financial
Inclusion Department, Customer Protection and Education Department. She
was the First Appellate authority under the Right to Information Act, as well
as the RBI nominee on the governing council of the Institute of Banking
Dr.Deepali Independen Personnel Selection and director on the Board of Bharatiya Reserve Bank
6 Pant Joshi t Director Note Mudran Private Limited part of the Board for Financial Supervision at
the RBI and the Board for Financial Supervision of RRBS and Co-operatives at
NABARD. Dr. Joshi is a macro policy analyst, a prolific writer with 9 acclaimed
books and a host of papers to her credit. She was Banking Ombudsman for
the State of Undivided Andhra Pradesh, Regional Director RBI Office. She
holds Law and Management Degree and is a fellow of the Harvard University
Asia Centre whereas a Fellow of the Harvard University she pursued
postdoctoral research in Economics and Finance.
Academic Research Project –Not a Recommendation
Commentary
Management remuneration
No of meetings
Name Designation Attendance at last AGM
Held Attended
Mr.Vellayan Non-Executive director and promotor 7 7 Present
Mr.Aun alagappan Executive and promotor 7 7 Present
Mr.sankarasubramaniyan Executive director 2 2 Not attended
Dr.Raghuram devarkonda Executive director 2 2 Not attended
Mr.Venkatachalam Non-executive director and promotor 7 7 Present
Non-executive and independent
Mr.Sumit bose 7 7 Present
director
Non-executive and independent
Ms.Aruna advani 7 7 Present
director
Non-executive and independent
Dr.Nagarajan 7 7 Present
director
Non-executive and independent
Mr.Parameshwaran 7 7 Present
director
Non-executive and independent
Mr.Sudarsan venu 7 5 Present
director
Non-executive and independent
Dr. Deepali pant Joshi 2 2 Not attended
director
Academic Research Project –Not a Recommendation
Revenue
Sales And Sales Growth
The revenue of company INR54.8b in 4QFY23, 29.5%
YoY higher .The company recorded a consolidated total 300000 60%
50%
income of Rs 7,033 Crores during the quarter. The sales 250000
40%
volume of 8.6 lakh metric tons during the quarter 18% 200000 30%
higher than the last year at 7.3 lakh metric tons.
150000 20%
Manufactured DAP plus complex volume is 7.6 lakh metric
10%
tons, higher by 10% over last year. The decrease in 100000
0%
revenue is mainly on account of drop-in subsidy rates in 50000 -10%
the fertilizer business compared to last year. Total
0 -20%
phosphate fertilizer manufacturing volumes including SSP
FY19 FY20 FY21 FY22 FY23 FY24E FY25E
grew 4% YoY while total manufacturing phosphate
fertilizer volumes (DAP and NPK) declined 1% YoY. Sales sales growth
Company’s Nutrient and Allied business focused on the
nutrient consumption. Lower primary sales about 7% and
fall in subsidy rates resulted in decline in the segment
revenue.
EBITDA and EBIDTA margin
Gross Margin 12000 14
10000 12
EBITDA grew by 6.2% in Q4FY23. In FY23.We expect 10
8000
the company to be able to improve margins through 8
efficient sourcing of raw materials, utilization of plant 6000
6
flexibility and expansion. Consolidated EBITDA for the 4000
4
quarter was Rs 1,059 Crores vis-à-vis Rs 1,057 Crores last 2000 2
year and for the half year it was Rs 1,768 Crores vis-à-vis
0 0
Rs 1,742 Crores during the last year. Subsidy businesses’
share in EBITDA stands at 81% during the quarter In the
previous year, it was 78% for both the quarter and first
half. Net profit after tax for the quarter was at Rs 755 EBITDA EBITDA Margin
Crores in comparison to Rs 741 Crores for the
corresponding quarter last year .
Annual snapshot
Quarterly snapshot
Particular INR mn FY22Q1 FY22Q2 FY22Q3 FY22Q4 FY23Q1 FY23Q2 FY23Q3 FY23Q4
Net sales 36639 61475 50726 42268 57291 101134 83096 54758
Total expenditure 31808 54043 45288 38471 50437 90564 75290 50726
EBITDA 4831 7432 5439 3797 6854 10570 7806 4032
EBITDA Margin 13.2 12.1 10.7 9 12 10.5 9.4 7.4
Depriciation 423 421 429 454 446 457 471 446
Interest 171 192 178 214 266 542 568 524
other income 218 189 269 768 536 311 396 469
PBT before EO expenses 4455 7008 5101 3897 6678 9881 7163 3531
Extra - ord expense 0 0 0 0 0 0 0 0
PBT 4455 7008 5101 3897 6678 9881 7163 3531
Tax rate 24.8 26 25.4 25.4 25.5 25.1 25 25.5
Academic Research Project –Not a Recommendation
INR 1076.45
52 Week (High - INR 4609 & Low - 3292)
Revenues (INR Crs.) Net Profit (INR Crs.) Average Total Assets (INR Crs.)
12,760
2,013
29,628
10,361 10,090
1,528 9,522
1,329
19,111
1,065
13,137 14,182
28.22% 2.70x
28.08%
27.75% 15.15% 15.78%
13.96% 2.01x
1.75x 1.79x
10.28%
26.56%
2020 2021 2022 2023 2020 2021 2022 2023 2020 2021 2022 2023
Academic Research Project –Not a Recommendation
Return on Asset